BPS3082
Applied pharmacokinetics, dynamics and product development
基本信息
| 学分 | 6 credit points |
|---|---|
| 开课学期 | Second semester |
| 校区 | Malaysia |
| 考核构成 | Laboratory report submission — 45% Laboratory performance and competence — 10% PK/PD take home assignment — 15% Mid-semester assessment — 30% |
开课安排1 条
| 教学期 | 授课方式 | 状态 |
|---|---|---|
| Second semester | Teaching activities are on-campus (ON-CAMPUS) | 开课 |
以上为该校区在官方资料中登记的全部开课安排，不是汇总。同一门课可能在多个 教学期开课，也可能不同教学期的授课方式不同。
课程简介
This unit integrates pharmacokinetics (PK) of drugs and product development, aiming to provide a full picture of how PK evaluation may impact formulation design and manufacture for medicines.
1.Pharmacokinetics (PK) and pharmacodynamics (PD)
You will be introduced to key techniques and concepts in the measurement, analysis and interpretation of PK/PD data for the development of pharmaceuticals. You will learn about important bioanalytical approaches required to generate PK datasets. You will receive datasets of model pharmaceuticals and learn to use PK/PD modelling and analyse these data. Based on an interpretation of the results regarding the physiological and physicochemical processes determining drug absorption, action and elimination, you will make recommendations on delivery options and dosage regimens for the model drugs.
2. Product design, protocol development, laboratory reporting and data analysis.
This component of the unit will provide opportunities for you to develop your employment-relevant research, teamwork and communication skills by producing scientifically sound solutions to produce a pharmaceutical product with thorough testing, evaluation and presentation. You will also develop the critical thinking skills necessary to make professionally informed decisions about the design of a scientific investigation as well as in the interpretation and communication of results.
以上为 Monash Handbook 的官方原文，版权属 Monash University，此处按本站要求转载并标注出处： 官方页面 ↗
学习成果9 条
官方原文（Learning outcomes），版权属 Monash University。
- ULO1 Discuss a range of important PK processes and behaviours and commonly used models to describe these;
- ULO2 Undertake PK and PK/PD modelling and simulations to inform clinical trial and drug development planning;
- ULO3 Apply advanced concepts in pharmaceutics to interpret PK/PD data and improve drug delivery and dose/regimen selection;
- ULO4 Define a research strategy to find, evaluate and organise authoritative and relevant information needed to solve the problem;
- ULO5 Construct a precise experimental protocol to investigate selected factors' effects;
- ULO6 Conduct experiments according to industry standards to produce and test products;
- ULO7 Methodically and systematically evaluate and analyse data, interpret observed phenomena and relate them to the initial hypotheses raised;
- ULO8 Communicate scientific findings and conclusions, and propose relevant solutions;
- ULO9 Work efficiently as a team.
教学方式与预期工作量
教学方式
Simulation or virtual practice
Online learning
Problem-based learning
Active learning
预期工作量
• Eight 1-2-hour online modules (discovery) and interactive content
• Two 2-hour applied Q&A sessions
• Two 1-hour applied Q&A sessions
• Five 2-hour workshops
• 10 hours of laboratory sessions
• 2 hours of assessments
官方原文，版权属 Monash University。
先修 / 同修要求
以下先修关系按官方来源的结构化先修字段解析，原始记号：BPS2041
先修链路
按官方先修字段的原始分组展开，AND / OR 的区别保留着—— 「A 或 B」和「A 与 B」在选课时是两回事。每门课点进去可以继续往下看。
互斥课程2 门
这些课和本课内容重叠，不能同时算进同一个学位（官方目录的 Prohibition 字段）。选了其中一门，另一门通常只能算选修学分甚至完全不计—— 这跟先修不同，先修是"没修过就不能选"，互斥是"修了也不能两门都算"。
原始记号：BPS3051 AND BPS3052
属于这些学位1 个
这门课出现在下列学位的官方结构里。反过来说：如果你读的是这些学位之一，它大概率是要修的 （必修还是选修取决于它在 Part 里的位置，点进去看结构）。
数据来源
- 数据来源
- 官方网页
handbook.monash.edu ↗ - 抓取时间
- 2026-09-13
- 可信度
- 程序抓取，未人工核实
查看官方完整描述 ↗ — 事实性字段（代码、学分、教学期、授课方式、考核权重、先修/同修/互斥关系）与 课程简介、学习成果、教学方式、预期工作量均取自官方 Handbook； 正文版权属 Monash University，此处转载并逐处标注出处。
发现信息有误？告诉我们。请用自己的话描述问题，不要上传成绩单、截图或校内系统文件。